Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Min Jeong Lee  (Lee MJ) 2 Articles
Bone Metabolism
Testosterone Replacement and Bone Mineral Density in Male Pituitary Tumor Patients
Min Jeong Lee, Hyoung Kyu Ryu, So-Yeon An, Ja Young Jeon, Ji In Lee, Yoon-Sok Chung
Endocrinol Metab. 2014;29(1):48-53.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.48
  • 3,503 View
  • 32 Download
  • 11 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   
Background

Hypopituitarism is associated with osteoporosis and osteopenia especially when hypogonadotropic hypogonadism is present. Despite hypopituitarism being an important cause of secondary osteoporosis, osteoporosis in patients receiving surgery for pituitary tumors in Korea has not been studied. In this study, we evaluated the effects of testosterone replacement therapy (TRT) on bone mineral density (BMD) in postoperative hypogonadal patients with pituitary tumors.

Methods

To examine the effect of TRT on BMD, we performed a retrospective observational study in 21 postoperative male patients who underwent pituitary tumor surgery between 2003 and 2012 at the Ajou University Hospital. Testosterone was replaced in postoperative hypogonadal patients by regular intramuscular injection, daily oral medication, or application of transdermal gel. BMD (g/cm2) measurements of central skeletal sites (lumbar spine, femoral neck, and total femur) were obtained using dual-energy X-ray absorptiometry (GE Lunar). For lumbar spine BMD, L1 to L4 values were chosen for analysis. Femur neck and total femur were also analyzed.

Results

During the follow-up period (mean, 56 months; range, 12 to 99 months) serum testosterone levels increased with the administration of TRT (P=0.007). There was significant improvement (4.56%±9.81%) in the lumbar spine BMD compared to baseline BMD. There were no significant changes in the femur neck BMD or total femur BMD. We did not find any statistically significant relationships between changes in testosterone levels and BMD using Spearman correlation analysis.

Conclusion

Our results indicated that TRT used in the postoperative period for hypogonadal pituitary tumor surgery patients may have beneficial effects on the BMD of the spine.

Citations

Citations to this article as recorded by  
  • Testosterone supplementation and bone parameters: a systematic review and meta-analysis study
    G. Corona, W. Vena, A. Pizzocaro, V. A. Giagulli, D. Francomano, G. Rastrelli, G. Mazziotti, A. Aversa, A. M. Isidori, R. Pivonello, L. Vignozzi, E. Mannucci, M. Maggi, A. Ferlin
    Journal of Endocrinological Investigation.2022; 45(5): 911.     CrossRef
  • Physiological testosterone replacement effects on male aged rats with orchiectomy-induced osteoporosis in advanced stage: a tomographic and biomechanical pilot study
    Vinícius de Paiva Gonçalves, Adriana Alicia Cabrera-Ortega, Jhonatan de Souza Carvalho, Dania Ramadan, Luís Carlos Spolidorio
    The Aging Male.2021; 24(1): 139.     CrossRef
  • Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
    Jia-Feng Chen, Pei-Wen Lin, Yi-Ru Tsai, Yi-Chien Yang, Hong-Yo Kang
    Cells.2019; 8(11): 1318.     CrossRef
  • Testosterone and male rejuvenation
    Sevann Helo, Peyton Thomas, Nicholas N. Tadros
    Panminerva Medica.2019;[Epub]     CrossRef
  • Systemic Non-Reproductive Effects of Sex Steroids in Adult Males and Females
    Syed Imran Ali Shah
    Human Physiology.2018; 44(1): 83.     CrossRef
  • Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
    Abdulmaged M. Traish
    Sexual Medicine Reviews.2018; 6(1): 86.     CrossRef
  • Multiple Fractures in Patient with Graves' Disease Accompanied by Isolated Hypogonadotropic Hypogonadism
    Hyon-Seung Yi, Ji Min Kim, Sang Hyeon Ju, Younghak Lee, Hyun Jin Kim, Koon Soon Kim
    Journal of Bone Metabolism.2016; 23(1): 40.     CrossRef
  • Severity and pattern of bone mineral loss in endocrine causes of osteoporosis as compared to age-related bone mineral loss
    D Dutta, P Dharmshaktu, A Aggarwal, K Gaurav, R Bansal, N Devru, UC Garga, B Kulshreshtha
    Journal of Postgraduate Medicine.2016; 62(3): 162.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Bone health in hypogonadal men
    Michael S. Irwig
    Current Opinion in Urology.2014; 24(6): 608.     CrossRef
  • Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
    Se Hwa Kim
    Endocrinology and Metabolism.2014; 29(1): 30.     CrossRef
Close layer
A Case of CATCH22 Syndrome with Normal Parathyroid Function.
Min Jeong Lee, So Yeon An, Chang Bum Bae, Young Bae Sohn, Yoon Sok Chung
Endocrinol Metab. 2012;27(2):151-154.   Published online June 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.2.151
  • 1,732 View
  • 19 Download
  • 1 Crossref
AbstractAbstract PDF
CATCH 22 is a medical acronym for cardiac defects, abnormal faces, thymic hypoplasia, cleft palate, and hypocalcemia, and a variable deletion on chromosome 22. It includes DiGeorge syndrome, conotruncal anomaly face syndrome, and velo-cardio-facial syndrome. It has a prevalence estimated at 1:3,000-1:6,000. Most deletions occur at de novo, but autosomal dominant inheritance is observed in 6-10% of cases. Hormonal disorders are common in patients with CATCH22 syndrome. While hypoparathyroidism was the predominant endocrine disturbance that has been documented in the DiGeorge syndrome, other hormonal defects, such as growth hormone deficiency, hypothyroidism, and hyperthyroidism have been occurred in patients with CATCH22 syndrome. The spectrum of parathyroid gland dysfunction in this syndrome ranges from severe neonatal hypocalcemia to normal parathyroid function. Most patients are usually diagnosed in young age, but a few patients with mild abnormality are presented later in life. We report a case of CATCH22 syndrome with normal parathyroid hormone and calcium level in an adult. The diagnosis of CATCH22 syndrome was confirmed by fluorescence in situ hybridization analysis.

Citations

Citations to this article as recorded by  
  • A Case of CATCH22 Syndrome Diagnosed in Postmenopausal Woman
    Seung Kyung Lee, Min Jeong Lee, Hyo Jin Lee, Bu Kyung Kim, Young Bae Sohn, Yoon-Sok Chung
    Journal of Bone Metabolism.2013; 20(1): 57.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism